Article

Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury

Departments of Molecular and Cellular Biochemistry, and Physical Therapy, and Biochemistry Program, The Ohio State University, Columbus, Ohio 43210, Department of Neurology, University of California at San Francisco, San Francisco, California 94121, and Department of Neurology and Neurological Science, Stanford University, Stanford, California 94305.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 01/2013; 33(2):397-410. DOI: 10.1523/JNEUROSCI.0399-12.2013
Source: PubMed

ABSTRACT The lack of effective therapies for spinal cord injury points to the need for identifying novel targets for therapeutic intervention. Here we report that a small molecule, LM11A-31, developed to block proNGF-p75 interaction and p75-mediated cell death crosses the blood-brain barrier efficiently when delivered orally. Administered starting 4 h postinjury, LM11A-31 promotes functional recovery without causing any toxicity or increased pain in a mouse model of spinal contusion injury. In both weight-bearing open-field tests and nonweight-bearing swim tests, LM11A-31 was effective in improving motor function and coordination. Such functional improvement correlated with a >50% increase in the number of surviving oligodendrocytes and myelinated axons. We also demonstrate that LM11A-31 indeed inhibits proNGF-p75 interaction in vivo, thereby curtailing the JNK3-mediated apoptotic cascade. These results thus highlight p75 as a novel therapeutic target for an orally delivered treatment for spinal cord injury.

1 Follower
 · 
72 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glial NG2-positive precursors are considered as suitable candidates for the cell-based therapies for disorders characterised by depletion of functional oligodendrocytes and ongoing hypo/demyelination. They are known to be among the first cells to react to CNS dysfunction. Their fate could be however considerably affected by the heterogeneity of the local tissue microenvironment. To address this issue, a comparison of mRNA expression of the crucial trophic factors was carried out in organotypic slices from the hippocampus (as a well-recognised neurogenic area) and from the spinal cord (where gliogenic signals are assumed to predominate). The molecular analysis revealed substantial differences in the mRNA levels of main factors governing cell biology. Additionally, the ability of these two microenvironments to promote the astrocytic differentiation of oligodendroglial progenitors was assessed as well. While the GFAP+ cells constituted the very minor population in control experiments, their amount increased significantly during culturing in the medium continuously conditioned by either hippocampal or the spinal cord slices. The observed susceptibility to the influence of the local extracellular signals might efficiently contribute to the reported glial scar formation. It presumably could also modify the fate of the endogenous or transplanted precursors, what should be taken into consideration in cell-based therapies.
    01/2013; 51(2):103-110. DOI:10.5114/fn.2013.35952
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The p75 neurotrophin receptor (p75(NTR)) is associated with multiple mechanisms linked to Alzheimer's disease (AD); hence, modulating its function might confer therapeutic effects. In previous in vitro work, we developed small molecule p75(NTR) ligands that inhibited amyloid-β-induced degenerative signaling and prevented neurite degeneration. In the present study, a prototype p75(NTR) ligand, LM11A-31, was administered orally to the Thy-1 hAPP(Lond/Swe) (APP(L/S)) AD mouse model. LM11A-31 reached brain concentrations known to inhibit degenerative signaling without toxicity or induction of hyperalgesia. It prevented deficits in novel object recognition after 2.5 months and, in a separate cohort, deficits in Y-maze performance after 3 months of treatment. Stereology studies found that the number and size of basal forebrain cholinergic neurons, which are normal in APP(L/S) mice, were unaffected. Neuritic dystrophy, however, was readily apparent in the basal forebrain, hippocampus and cortex, and was significantly reduced by LM11A-31, with no effect on amyloid levels. These studies reveal that p75(NTR) is an important and tractable in vivo drug target for AD, with LM11A-31 representing a novel class of therapeutic candidates.
    Neurobiology of aging 03/2013; 34(8). DOI:10.1016/j.neurobiolaging.2013.02.015 · 4.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neural stem/progenitor cells (NSCs) proliferate and differentiate under tight regulation by various factors in the stem cell niche. Recent studies have shown that the precursor of nerve growth factor (NGF), proNGF, abounds in the central nervous system (CNS) and that its expression level in the brain is substantially elevated with aging as well as in several types of CNS disorders. In this study, we found for the first time that proNGF inhibited the proliferation of NSCs isolated from postnatal mouse hippocampus and caused cell cycle arrest in the G0/G1 phase without affecting apoptosis. In addition, proNGF reduced the differentiation of NSCs to oligodendrocytes. The effects of proNGF were blocked by the fusion protein of p75 neurotrophin receptor extracellular domain and human IgG Fc fragment (p75NTR/Fc), and by p75NTR knockout, suggesting that proNGF/p75NTR interaction was involved in the effects of proNGF on NSC proliferation and differentiation. proNGF decreased the phosphorylation level of extracellular signal responsive kinase 1/2 (ERK 1/2) in a p75NTR-dependent manner under both self-renewal and differentiation conditions. The inhibition of ERK 1/2 phosphorylation by U0126 significantly reduced the proliferation and oligodendrogenesis of NSCs, indicating that ERK 1/2 inhibition by proNGF partially explains its effects on NSC proliferation and oligodendrogenesis. These results suggest that the proNGF/p75NTR signal plays a key role in the regulation of NSCs' behavior.
    Stem Cell Research 05/2013; 11(2):874-887. DOI:10.1016/j.scr.2013.05.004 · 3.91 Impact Factor
Show more